Dyadic International Inc
DYAI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001213809
In the last 90 days, Dyadic International Inc insiders filed 0 open-market purchases and 2 sales; 39 institutions reported holding it in 13F filings for Q2 2026, worth $4.14M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Dyadic International Inc changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 32 | 32 | 0 |
| Shares | 4.49M | 4.45M | −47.2K (−1.1%) |
| Value | $5.52M | $7.91M | +$2.39M (+43.2%) |
New holders (3)
Institutions that held Dyadic International Inc at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Captrust Financial Advisors | 15,000 | $26.7K | 0.00% |
| Two Sigma Securities, LLC | 13,089 | $23.3K | 0.00% |
| Virtu Financial LLC | 11,248 | $20.0K | 0.00% |
Sold out (3)
Institutions that held Dyadic International Inc at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Forefront Analytics, LLC | 57,094 | $70.2K |
| Susquehanna Fundamental Investments, LLC | 12,276 | $15.1K |
| Lee Financial Co | 3,000 | $3.69K |